Association Between Metabolic Clusters and Microbial Age in High-Risk Populations for Diabetes and Their Potential Impact on Cardiovascular Disease Risk: Cross-Sectional Observational Study - Top-Institutions - MDSpire

Link Between Metabolic Profiles and Microbial Age in High-Risk Diabetes Populations and Their Possible Influence on Cardiovascular Disease Risk: A Cross-Sectional Observational Analysis

  • By

  • Lu Xinlin

  • Hongli Gu

  • Ren Li

  • Xianjun Mao

  • Can Chen

  • May 26, 2026

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Metabolomics

  • #2

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Metabolomics

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Metabolomics

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Metabolomics

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, California

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Metabolomics

Original Source(s)

Association Between Metabolic Clusters and Microbial Age in High-Risk Populations for Diabetes and Their Potential Impact on Cardiovascular Disease Risk: Cross-Sectional Observational Study

  • by Lu Xinlin, Hongli Gu, Ren Li, Xianjun Mao, Can Chen

  • May 26, 2026

Related Content

Determinants of metabolic dysfunction associated steatotic liver disease and liver fibrosis in patients with type 2 diabetes mellitus: a cross-sectional study

Psychoneuroimmunological changes in adults with obesity receiving chiropractic care: a single-arm pilot trial

CGM Linked to More Time in Range

In a randomized crossover trial of insulin-treated patients receiving hemodialysis, real-time continuous glucose monitoring did not improve the primary hypoglycemia outcome but increased time in range and reduced time above range vs capillary testing.